---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-025975"
form_type: "8-K"
ticker: "PLSH"
cik: "0001552189"
company_name: "PANACEA LIFE SCIENCES HOLDINGS, INC."
filed_at: "2021-10-21T23:59:59+00:00"
generated_at: "2026-06-28T19:11:52.822893+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Exactus adds Dr. Janice Nerger to board of directors

## Summary
- Dr. Janice Nerger officially became a director on October 17, 2021.
- Appointment followed compliance with Rule 14f-1 under the Exchange Act.
- No other changes to board or officer positions were disclosed.

## SEC filing metadata
- accession: 0001493152-21-025975
- form_type: 8-K
- ticker: PLSH
- cik: 0001552189
- company_name: PANACEA LIFE SCIENCES HOLDINGS, INC.
- filed_at: 2021-10-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1552189/000149315221025975/0001493152-21-025975-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1552189/000149315221025975/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-025975
- JSON: https://secwatch.observer/filing/0001493152-21-025975.json
- Plain text: https://secwatch.observer/filing/0001493152-21-025975.txt

## Key facts
- Executive change
  Dr. Janice Nerger was appointed as director at PANACEA LIFE SCIENCES HOLDINGS, INC..
  - Action: appointed
  - Role: director
  source text: On October 17, 2021, following Exactus, Inc. (the “Company”) compliance with Rule 14f-1 under the Securities Exchange Act of 1934, Dr. Janice Nerger officially became a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1552189/000149315221025975/0001493152-21-025975-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.